Aclarion, Inc. (NASDAQ:ACON – Get Free Report) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 122,800 shares, a drop of 73.9% from the February 28th total of 471,200 shares. Based on an average daily volume of 4,910,000 shares, the short-interest ratio is currently 0.0 days. Currently, 24.3% of the shares of the stock are short sold.
Aclarion Stock Down 14.0 %
Shares of Aclarion stock opened at $12.12 on Friday. The company has a 50 day moving average of $3.15 and a 200-day moving average of $35.61. Aclarion has a 1-year low of $11.36 and a 1-year high of $6,241.05.
Wall Street Analyst Weigh In
Separately, Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a research note on Friday, December 13th.
Aclarion Company Profile
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Featured Stories
- Five stocks we like better than Aclarion
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Following Congress Stock Trades
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
